PLEDPHARMA AB (PUBL) Chart calendar PledPharma AB (publ)
5bbb9fa2e9b8fc5dee7a1c630.2LnLV1UR6Cop39LsDD6SKTLecuJXGGpjZJCRRmvS2Co.oc6aYzcm0Bpel6TcT2r7UEiqHKseYTJOAMGnF1Ocs2y5_PtjLyahS2fm4g~3bcc12357f955bfda29d66115e037362
Upcoming events on PledPharma AB (publ)
Past events on PledPharma AB (publ)
| 2024-04-18 11:50 am | Redeye Investor Forum |
| 2024-03-04 | Carnegie Healthcare Conference |
| 2024-02-21 | Q4 2023 Earnings Release |
| 2023-12-18 | Investor Day |
| 2023-11-07 | Q3 2023 Earnings Release |
| 2023-08-21 | Q2 2023 Earnings Release |
| 2023-05-30 12:00 am | ABGSC Life Science Summit |
| 2023-04-26 | Annual General Meeting |
| 2023-04-25 | Q1 2023 Earnings Release |
| 2023-02-21 | FY 2022 Earnings Release |
| 2022-11-07 | Q3 2022 Earnings Release |
| 2022-10-18 | American Thyroid Association Meeting |
| 2022-10-13 07:00 am | Capital Markets Day |
| 2022-10-02 | International Child Neurology Congress |
| 2022-09-14 | European Society of Paediatric Endocrinology Meeting |
| 2022-09-09 | European Thyroid Association Meeting |
| 2022-09-06 | Pareto Securities Healthcare Conference |
| 2022-08-30 | Redeye Late Stage Life Science Day |
| 2022-08-29 | Society for the Study of Inborn Errors of Metabolism Symposium |
| 2022-08-23 | Erik Penser Bank Company Day |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 28,2 46,5 -39.33% | 82,6 73,0 13.07% | 40,7 39,8 2.28% | 38,5 49,1 -21.56% | 22,6 29,2 -22.63% | 57,6 35,4 62.54% |
|
EBITDA Million SEK | Released Forecast Spread | -92,5 -74,7 -23.84% | -66,5 -89,2 25.49% | -178 -133 -33.78% | -103 -127 19.03% | -195 -163 -19.8% | -321 -286 -12.41% |
|
EBIT Million SEK | Released Forecast Spread | -92,5 -74,7 -23.84% | -66,7 -89,4 25.43% | -178 -133 -34.01% | -106 -128 17.18% | -198 -165 -19.71% | -325 -288 -12.92% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -85,0 -71,1 -19.5% | -61,4 -76,7 19.9% | -179 -131 -36.83% | -105 -128 18.52% | -194 -159 -21.69% | -327 -287 -14.05% |
|
Net income Million SEK | Released Forecast Spread | -85,0 -71,1 -19.5% | -61,4 -76,7 19.9% | -179 -131 -36.83% | -105 -128 18.52% | -194 -159 -21.69% | -327 -287 -14.08% |
|
EPS SEK | Released Forecast Spread | -1,70 -1,47 -16.04% | -1,20 -1,49 19.24% | -2,70 -1,35 -100.44% | -0,60 -0,78 23.04% | -1,00 -0,85 -17.19% | -1,30 -1,22 -6.57% |
| Announcement Date | 21/02/19 | 18/02/20 | 17/02/21 | 17/02/22 | 22/02/23 | 22/02/24 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 6,21 4,00 55.25% | 3,51 4,00 -12.23% | 5,02 10,4 -51.61% | 5,10 10,4 -50.87% | 5,70 10,4 -45.09% | 6,80 5,62 20.98% | 5,90 5,25 12.3% | 12,2 5,25 132.2% | 32,6 8,30 292.77% | 10,0 | 9,00 | 10,0 | 10,0 | |
|
EBITDA Million SEK | Released Forecast Spread | -18,9 -39,0 51.48% | -31,9 -37,0 13.65% | -34,3 -45,4 24.38% | -54,7 -45,4 -20.57% | -77,5 -45,4 -70.83% | -74,0 -82,0 9.76% | -79,4 -71,7 -10.79% | -85,6 -73,1 -17.17% | -82,2 -83,9 2.01% | -86,0 | -85,0 | -85,0 | -85,0 | |
|
EBIT Million SEK | Released Forecast Spread | -19,6 -39,0 49.77% | -32,6 -37,0 11.84% | -35,0 -45,4 22.89% | -55,4 -45,4 -22.11% | -78,2 -45,4 -72.37% | -74,9 -82,0 8.66% | -80,3 -71,7 -12.05% | -86,5 -73,1 -18.4% | -83,1 -83,9 0.93% | -86,0 | -85,0 | -85,0 | -85,0 | |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -22,5 -40,3 44.11% | -32,1 -38,4 16.47% | -33,2 -48,0 30.77% | -53,9 -48,0 -12.24% | -77,8 -48,0 -62.02% | -74,9 -80,8 7.26% | -79,5 -71,0 -11.97% | -86,2 -72,7 -18.57% | -86,1 -87,3 1.34% | -89,4 | -88,4 | -94,3 | -94,6 | |
|
Net income Million SEK | Released Forecast Spread | -22,5 -40,3 44.11% | -32,1 -38,4 16.47% | -28,8 | -33,2 -48,0 30.77% | -53,1 -48,0 -10.56% | -77,8 -48,0 -62.02% | -74,9 -80,8 7.26% | -79,5 -71,0 -11.97% | -86,2 -72,7 -18.57% | -86,3 -87,3 1.11% | -89,4 | -88,4 | -94,3 | -94,6 |
|
EPS SEK | Released Forecast Spread | -0,10 -0,24 59.05% | -0,20 -0,23 13.98% | -0,20 | -0,20 -0,22 10.63% | -0,30 -0,22 -34.06% | -0,40 -0,22 -78.75% | -0,30 -0,35 13.79% | -0,30 -0,28 -5.46% | -0,30 -0,26 -14.6% | -0,30 -0,32 6.81% | -0,31 | -0,30 | -0,32 | -0,31 |
| Announcement Date | 04/11/21 | 17/02/22 | 26/04/22 | 19/08/22 | 08/11/22 | 22/02/23 | 26/04/23 | 22/08/23 | 08/11/23 | 22/02/24 | - | - | - | - |
More events
Past sector events for PledPharma AB (publ)
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
